From Our Partners
Sunday, July 3, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

BARDA Seeks Vaccine Ancillary Materials for Pandemic Preparedness

by Global Biodefense Staff
May 14, 2013

Research on CBRN Medical CountermeasuresThe Department of Health and Human Services (HHS) intends to issue a Request for Proposal (RFP) for ancillary materials such as needles, syringes, combination units and isopropyl alcohol prep pads to meet the vaccine administration needs of the public during a pandemic influenza event.

To ensure coverage, manufacturers are expected to acquire, maintain and rotate inventories of integrated needle and syringe units of various types directed by the Biological Advanced Research and Development Authority (BARDA). The effort seeks to provide long-term solutions that satisfy vaccine administration requirements during pandemic events and account for recent technology advances in vaccine manufacturing where the ability to produce influenza vaccines may outstrip the capability of manufacturers to maintain pace with sufficient syringe units.

Highlighted RFP requirements include the manufacture and purchase availability of up to:

512 million FDA approved integrated needle and syringe combination units
88 million FDA approved needles, safety engineered, of the following sizes: 23Gx1″, 25Gx1″, 25Gx5/8″
88 million FDA approved 3ml Syringes, luer lock, safety engineered
600 million Isopropyl Alcohol Impregnated Prep Pads, sterile, individually sealed, small
300 million FDA approved integrated needle and syringe combination units (conventional)

Supplier must also provide a manufacturing production schedule representative of the surge capacity that can be made available to the USG for pandemic planning purposes. 

The RFP is estimated to be avalabe through FBO.gov on or about May 17, 2013 with proposals being due June 18, 2013.  Multiple awards may result from this solicitation with an estimated award date of around July 2013. Further details are available under Solicitation Number: 13-100-SOL-00015.

From Our Partners
Tags: ASPRBARDAHHSInfluenzaPandemicRequest for ProposalsVaccines

Related Posts

NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster
Preparedness

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity
Biosecurity

U.S. Fish and Wildlife Service Opens Grant Program to Shore Up Avian Flu Biosecurity

April 13, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC